Stelara is a biologic medicine used to treat moderate to severe Crohn’s disease and ulcerative colitis. Crohn’s disease and ulcerative colitis are inflammatory bowel diseases that cause inflammation ...

The new molecules selectively reduced inflammatory signaling in human immune cells without affecting other immune pathways. Treatment with the molecules also reduced inflammation in mice with the ...

FRESNO, Calif. (KFSN) -- December 1-7 is Crohn's and Colitis Awareness Week - a time to shine a light on the two main forms of inflammatory bowel disease (IBD). They're considered invisible illnesses ...

An estimated 3 million Americans have an inflammatory bowel disease (IBD) such as Crohn's disease or ulcerative colitis. But ...

"What should I eat?" is perhaps the most common question patients with inflammatory bowel disease ask their doctors.

News and commentary from the world of gastroenterology and hepatology ...

Cytomegalovirus (CMV) is a ubiquitous herpesvirus that, while often latent in the general population, can become reactivated in individuals with compromised immune systems. Inflammatory bowel disease ...

Noninfectious gastroenteritis and colitis are both conditions that affect your digestive tract. While they may lead to similar symptoms, they can have different causes, risk factors, and treatments.

Continuation of 5-ASA Therapy in IBD? When inflammatory bowel disease (IBD) patients are doing well on immunomodulators, should they be continued on 5-aminosalicylic acid (5-ASA) therapy? Sunanda Kane ...

Among patients with inflammatory bowel disease (IBD), overlapping biologic therapy was common during medication switches and was not associated with a higher risk for infection than nonoverlapping ...

For first-degree relatives of patients with Crohn disease, increased antibody response is associated with subsequent risk for CD.